The study of neurological disorders using positron emission tomography and single photon emission computed tomography

Journal of the Neurological Sciences

Volumn 135, Issue 2, 1996, Pages 91-108

  Newberg, Andrew B ^a   Alavi, Abass ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Neurological disorders; PET; SPECT

Indexed keywords

AGING; HUMAN; NEUROLOGIC DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030040439     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00289-E     Document Type: Review

References (263)

1. Abdel-Dayem, H.M., Sadek, S.A. and Kouris, K. (1987) Changes in cerebral perfusion after acute head injury, Comparison of CT with Tc-99m HM-PAO SPECT. Radiol., 165: 221-226.
2. Agnoli, A., Fabbrini, G. and Fioravanti, M., et al. (1992) CBF and cognitive evaluation of Alzheimer type patients before and after IMAO-B treatment: a pilot study. Eur. Neuropsychopharmacol., 2: 31-35.
3. Alavi, A. (1989a) Functional and anatomical studies of head injury. J. Neuropsych., 1: S45-50.
4. Alavi, A. and Hirsch, L.J. (1991) Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades. Semin. Nucl. Med., 21: 58-81.
5. Alavi, A. (1989b) The aging brain. J. Neuropsych., 1: S51-55 (Suppl. 1).
6. Alavi, A., Dann, R. and Chawluk, J., et al. (1986) Positron emission tomography imaging of regional cerbral glucose metabolism, Semin. Nucl. Med., 16: 2-34.
7. Alavi, A., Fazekas, T. and Alves, W., et al. (1987) Positron emission tomography in the evaluation of head injury. J. Cerebr. Blood Flow Metab., 7: S646. (Suppl 1: Abstr.).
8. Alavi, A., Gosfield, T. and Cho, W., et al. (1990) Unusual patterns of cerebellar hypometabolism in head trauma (HT) J. Nucl. Med., 31: 741 (abstr.).
9. Alavi, A., Newberg, A. and Souder, E., et al. (1992) Comparison of quantitative MRI and PET between patients with dementia of the Alzheimer type and multi-infarct dementia. J. Stroke Cerebrovasc. Dis., 2: 218-221.
10. Alavi, A., Newberg, A. and Souder, E., et al. (1993) Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: Atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J. Nucl. Med., 34: 1681-1687.
11. Alavi, A., Reivich, M. and Ferris, S., et al. (1982a) Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography. In: Hoyer, S. (Ed.) The Aging Brain - Physiological and Pathophysiological Aspects, Springer-Verlag, Berlin, pp. 87-195.
12. Alavi, A., Reivich, M. and Jones, S., et al. (1982b) Functional imaging of the brain with positron emission tomography. Nucl. Med. Ann., 10: 319-372.
13. Alavi, J., Alavi, A. and Dann, R., et al. (1985) Metabolic brain imaging correlated with clinical features and brain tumors. J. Nucl. Med., 18: P64: (abstr).
14. Alavi, J.B., Alavi, A. and Chawluk, J., et al. (1988) Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62: 1074-1078.
15. Albert, M., Naeser, M.A. and Levine, H.L., et al. (1984) Ventricular size in patients with presenile dementia of the Alzheimer type. Arch. Neurol., 41: 1258-1263.
16. Barker, P.B., Glickson, J.D. and Bryan, R.N. (1993) In vivo magnetic resonance spectroscopy of human brain tumors. Top. Magn. Res. Imag., 5: 32-45.
17. Baron, J., Bousser, M. and Comar, D., et al. (1980) Crossed cerebellar diaschisis, in human supratentorial brain infarction. Trans Am. Neurol. Assoc., 105: 459-461.
18. Baron, J., Bousser, M. and Rey, A., et al. (1981) Reversal of focal 'misery-perfusion syndrome' by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. Stroke, 12: 454-459.
19. Baron, J., Frackowiak, R. and Herholz, K., et al. (1989) Use of PET methods for measurement of cerebral energy metabolism and hemo-dynamics in cerebrovascular disease. J. Cerebr. Blood Flow Metab. 9: 723-742.
20. 2: Prognostic value in recent supratentorial infarction in humans. J. Cerebr. Blood Flow Metab. 3: A-2. (Suppl A).
21. Baron, J., Rougemont, D. and Bousser, M., et al. (1984) Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients. J. Cerebr. Blood Flow Metab., 4: 140-149.
22. Beaney, R.P., Brooks, D.J. and Leenders, K.L., et al. (1985) Blood flow and oxygen utilization in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery. J. Neurol. Neurosurg. Psych., 48: 310-319.
23. Benson, D.F., Kuhl, D.E. and Hawkins, R.A., et al. (1983) The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch. Neurol., 40: 711-714.
24. Berent, S., Goerdani, B. and Lehtinen, S., et al. (1988) Positron emission tomographic scan investigations of Huntington's disease, Cerebral metabolic correlates of cognitive function. Ann. Neurol., 23: 541-546.
25. Bernardi, S., Trimble, M.R. and Frackowiak, R.S.J., et al. (1983) An interictal study of partial epilepsy using positron emission tomography and oxygen 15 inhalation method. J. Neurol. Neurosurg. Psych., 46: 473-477.
26. Bhatt, M.H., Snow, B.J. and Calne, D.R., et al. (1991) Fluorodopa PET studies of twins in idiopathic parkinsonism. 10th International Symposium on Parkinson's Disease, (Abstr.).
27. Black, K.L., Hawkins, R.A. and Kim, K.T., et al. (1989) Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J. Neurosurg., 71: 342-346.
28. Blesa, R. and Blin, J., et al. (1991) Levodopa-reduced glucose metabolism in striatopallidothalamocortico circuit in Parkinson's disease. Neurology, 41 (Suppl. 1): 359.
29. Blom, R.J., Vinuela, F. and Fox, A.J., et al. (1984) Computed tomography in temporal lobe epilepsy. JCAT 8: 401-405.
30. Bonte, F.J., Devous, M.D. and Stokely, E., et al. (1983) Single-photon tomographic determination of regional cerebral blood flow in epilepsy. A.J.N.R., 4: 544-546.
31. Bonte, F.J., Hom, J. and Tintner, R., et al. (1990) Single photon tomography in Alzheimer's disease and the dementias. Semin. Nucl. Med., 20: 342-352.
32. Bonte, F.J., Ross, E.D. and Chehabi, H.H., et al. (1986) SPECT study of regional cerebral blood flow in Alzheimer disease. J. Comput. Assist. Tomograph., 10: 579-583.
33. Bose, A., Pacia, S.B. and Fayad, P., et al. (1990) Cerebral blood flow imaging compared to CT during the initial 24 hours of cerebral infarction. Neurology, 40: 190.
34. Bottomley, P.A., Cousins, J.P. and Pendrey, D.L., et al. (1992) Alzheimer's dementia: Quantification of energy metabolism and mobile phosphoesters with P-31 NMR spectroscopy. Radiology, 183: 695.
35. Bradley, W.G., Waluch, V. and Yadley, R.A., et al. (1984) Comparison of CT and MR in 400 patients with suspected disease of the brain and cervical spinal cord. Radiology, 152: 695-702.
36. Braffman, B.H., Grossman, R.I. and Goldberg, H.I., et al.(1989) MR imaging of Parkinson's disease with spin-echo and gradient sequences. A.J.R., 152: 159-165.
37. Brandt-Zawadski, M., Fein, G. and Van Dyke, D., et al. (1985) MR imaging of the aging brain: Patchy white matter lesions and dementia. A.J.N.R., 6: 675-82.
38. Broich, K., Alavi, A. and Kushner, M. (1992) Positron emission tomography in cerebrovascular disorders. Semin. Nucl. Med., 22: 224-232.
39. Brooks, D.J. (1989) Positron emission tomographic studies of the subcortical degenerations and dystonias. Semin. Neurol., 9: 351-359.
40. Brooks, D.J. (1991a) Detection of preclinical Parkinson's disease with PET. Neurology, 4 (Suppl 2): 24-27.
41. Brooks, D.J. (1991b) The clinical role of PET in cerebrovascular disease. Neurosurg. Rev., 14: 91-96.
42. Brooks, D.J., Ibanez, V. and Sawle, G.V., et al. (1990) Differing patterns of striatal (18F)-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann. Neurol., 28: 547-555.
43. Brown, G.G., Levine, S.R., Gorell, J.M., et al. (1989) In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology, 39: 1423.
44. Bucher, S.F., Seelos, K.C. and Stehling, M., et al. (1995) High-resolution activation mapping of basal ganglia with functional magnetic resonance imaging. Neurology, 45: 180-182.
45. Buell, U., Braun, H. and Ferbert, A., et al. (1988) Combined SPECT imaing of regional cerebral blood flow (99mTc-hexamethyl-propyleneamine oxime, HMPAO) and blood voluem (99mTc-RBC) to assess regional cerebral perfusion reserve in patients with cerebrovascular disease. Nuklearmedzin, 27: 51-56.
46. Buell, U., Moser, E.A. and Schmiedek, P., et al. (1984) Dynamic SPECT with 133 Xe, Regional cerebral blood flow in patients with unilateral cerebrovascular disease. Concise Communication. J. Nucl. Med., 25: 441-446.
47. Cascino, G.D., Jack, C.R. Jr. and Parisi, J.E., et al. (1992) MRI in the presurgical evaluation of patients with frontal lobe epilepsy and children with temporal lobe epilepsy, pathological correlation and prognostic importance. Epilepsy Res., 11: 51-59.
48. Chawluk, J.B., Alavi, A. and Dann, R., et al. (1987b) Positron emission tomography in aging and dementia: effect of cerebral atrophy. J. Nucl. Med., 28: 431-7.
49. Chawluk, J.B., Alavi, A. and Hurtig, H., et al. (1985) Altered patterns of regional cerebral glucose metabolism in aging and dementia. J. Cerebr. Blood Flow Melab., 5: S121-2, 1985.
50. Chawluk, J.B., Alavi, A. and Jamieson, D.G., et al. (1987) Changes in local cerebral glucose metabolism with normal aging, the effects of cardiovascular and systemic health factors. J. Cerebr. Blood Flow Metab., 7: S411.
51. Chollet, F., Celsis, P. and Clanet, M., et al. (1989) SPECT study of cerebral blood flow reactivity after acetazolamide in patients with transient ischemic attacks. Stroke, 20: 458-464.
52. Clark, C., Hayden, M. and Hollenberg, S., et al. (1987) Controlling for cerebral atrophy in positron emission tomography data. J. Cerebr. Blood Flow Metab., 7: 510-2.
53. Cohen, M.B., Graham, L.S. and Lake, R., et al. (1986) Diagnosis of Alzheimer's disease and multiple infarct dementia by tomographic imaging of iodine-123 IMP. J. Nucl. Med., 27: 769-774.
54. Coleman, R.E., Hoffman, J.M. and Hanson, M.W., et al. (1991) Clinical application of PET for the evaluation of brain tumors. J. Nucl. Med., 32: 616-622.
55. Crow, W. (1991) Aspects of neuroradiology of head injury. Neurosurg. Clin. N. Am., 2: 321-339.
56. Cutler, N.R., Haxby, J. and Duara, R., et al. (1985a) Clinical history, brain metabolism and neurophysiological function in Alzheimer's disease. Ann. Neurol., 18: 298-309.
57. Cutler, N.R., Haxby, J.C. and Duara, R., et al. (1985b) Brain metabolism as measured with positron emission tomography: Serial assessment in a patient with familial Alzheimer's disease. Neurology, 35: 1556-1561.
58. Damasio, H., Eslinger, P. and Damasio, A.R., et al. (1983) Quantitative computed tomography analysis in the diagnosis of dementia. Arch. Neurol. 40: 715-719.
59. Davidson, J. (1989) A new approach to brain imaging. Radiograph. Tod., 55: 19.
60. De Roo, M., Mortelmans, L. and Devos, P., et al. (1989) Clinical experience with Tc-99m HM-PAO high resolution SPECT of the brain in patients with cerebrovascular accidents. Eur. J. Nucl. Med., 15: 9-15.
61. Defer, G., Moretti, J.L. and Cesaro, P., et al. (1987) Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia, A prognostic index for clinical recovery. Arch. Neurol., 44: 715-718.
62. DeKosky, S.T., Shih, W.J. and Schmitt, F.A., et al. (1990) Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: correlation with cognitive severity. Alzheimer Dis. Assoc. Disord., 4: 14-23.
63. DeLaPaz, R.L., Patronas, N.J. and Brooks, R.A., et al. (1983) Positron emission tomographic study of suppression of gray matter glucose utilization by brain tumors. A.J.N.R., 4: 826-829.
64. deLeon, M., George, A. and Tomanelli, J., et al. (1987) Positron emission tomography studies of normal aging, a replication of PET III and 18-FDG using PET IV and II-CDG. Neurobiol. Aging, 8: 319-323.
65. deLeon, M.J., Gerris, S.H. and George, A.E. et al. (1983) Computed tomography and positron emission transaxial tomography evaluatons of normal aging and Alzheimer's disease. J. Cerebr. Blood Flow Metab., 3: 391-394.
66. Demeurisse, G., Verhas, M. and Capon, A., et al. (1983) Lack of evolution of the cerebral blood flow during clinical recovery of a stroke. Stroke, 14: 77-81.
67. Derouesne, C., Rancurel, G. and Le Poncin, et al. (1985) Variability of cerebral blood flow defects in Alzheimer's disease on 123-iodo-isopropyl-amphetamine and single-photon emission tomgraphy. Lancet i: 1282 (Letter).
68. Deutsch, G. and Tweedy, J.R. (1987) Cerebral blood flow in severity matched Alzheimer and multi-infarct patients. Neurology, 37: 431-438.
69. Dewan, M.J. and Gupta, S. (1992) Toward a definite diagnosis of Alzheimer's disease. Comparative Psychiatry 33: 282-290.
70. 18F) fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest. Radiol., 22: 360-371.
71. 18F Fluorodeoxy-glucose and positron emission tomography. Neurology, 32: 1323-1329.
72. DiPiero, V., Chollet, F.M. and MacCarthy, P., et al. (1992) Motor recovery after acute ischaemic stroke, a metabolic study. J. Neurol. Neurosurg. Psych., 55: 990-996.
73. Dooms, G.C., Hecht, S. and Brant-Zawadzki, M., et al. (1986) Brain radiation lesions, MR imaging. Radiology, 158: 149-55.
74. 82Rb positron emission tomography. J. Comput. Axial Tomograph., 11: 563-570.
75. Drayer, B.P. (1988) Imaging of the aging brain. Part 1. Radiol., 166: 785-796.
76. Duara, R. (1990) Utilization of positron emission tomography in research and clinical applications. In: Duara, R. (Ed.) Frontiers of Clinical Neuroscience. Vol. 10, Wiley Liss, New York, pp. 1-12.
77. Duara, R., Barker, W. and Loewenstein, D., et al. (1989) Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia. Eur. Neurol., 29: 9-15.
78. Duara, R., Grady, C. and Haxby, J., et al. (1986) Positron emission tomography in Alzheimer's disease. Neurology, 36: 879-887.
79. Duncan, R. (1992) Epilepsy, cerebral blood flow and cerebral metabolic rate. Cerebrovasc. Brain Metab. Rev. 4: 105-121.
80. Eidelberg, D., Moeller, J.R. and Dhawan, V., et al. (1990) The metabolic anatomy of Parkinson's disease, Complementart (18F) fluorodeoxyglucose and (18F) fluorodopa positron emission tomographic studies. Movement Dis., 5: 203-213.
81. Engel, J. Jr. (1991) PET scanning inpartial epilepsy. Can. J. Neurol. Sci., 18 (Suppl): 588-592.
82. Engel, J. Jr., Brown, W.J. and Kuhl, D.E., et al. (1982a) Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann. Neurol., 12: 518-528.
83. Engel, J. Jr., Kuhl, D.E. and Phelps, M.E., et al. (1982b) Comparative localization of the epileptic foci in partial epilepsy by PCT and EEG. Ann. Neurol., 12: 529-537.
84. Engel, J. Jr., Kuhl, D.E. and Phelps, M.E., et al. (1983) Local cerebral metabolism during partial seizures. Neurology, 33: 400-413.
85. Erkinjuntti, T., Ketonen, L. and Sulkave, R., et al. (1987) Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? J. Neurol. Neurosurg. Psych., 50: 37-42.
86. Fazekas, F., Alavi, A. and Chawluk, J.B., et al. (1989) Comparison of CT, MR and PET in Alzheimer's dementia and normal aging. J. Nucl. Med., 30: 1607-1615.
87. Fazekas, F., Chawluk, J.B. and Alavi, A., et al. (1987) MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. A.J.N.R., 8: 421-426.
88. Felix, R., Schorner, W. and Laniado, M., et al. (1985) Brain tumors, MR imaging with Gadolinium-DTPA. Radiology, 156: 681-688.
89. Foster, N.L., Mann, U. and Mohr, E., et al. (1989) Focal cerebral glucose hypometabolism in definite Alzheimer's disease. Ann. Neurol., 26: 132-133.
90. Frackowiak, R., Pozilli, C. and Legg, N., et al. (1981) Regional cerebral oxygen supply and utilization in dementia: A clinical and physiological study with oxygen-15 and positron emission tomography. Brain, 104: 753-788.
91. Franck, G., Maquet, P. and Sadzot, B., et al. (1992) Contribution of positron emission tomography to the investigation of epilepsies of frontal lobe origin. Adv. Neurol., 57: 471-485.
92. 18F) fluorodeoxyglucose. J. Comp. Assist. Tomography, 7: 590-598.
93. Friedland, R.P., Budinger, T.F. and Koss, E., et al. (1985) Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization, Neurosci. Lett., 53: 235-240.
94. Friedland, R.P., Jagust, W.J. and Huesman, R.H., et al. (1989) Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology, 39: 1427-1434.
95. Frost, J.J., Mayhberg, H.S. and Fisher, R.S., et al. (1988) Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann. Neurol., 23: 231-237.
96. Fumeya, H., Ito, K. Yamaguwa, O. et al. (1990) Analysis of MRI and SPECT in patients with acute head injury. Acta Neurochir., (Suppl.) 51: 283-285.
97. Gado, M.H., Hughes, C.P. and Danziger, W., et al. (1982) Volumetric measurements of the cerebrospinal fluid spaces in subjects with dementia and in controls. Radiology, 144: 535-538.
98. Gado, M.H., Hughes, C.P. and Danziger, W., et al. (1983) Aging, dementia and brain atrophy: A longitudinal computed tomography study. A.J.N.R., 4: 699-702.
99. Gemmell, H.G., Sharp, P.F. and Besson, J.A.O., et al. (1987) Differential diagnosis in dementia using the cerebral blood flow agent 99mTC HM-PAO, A SPECT study. J. Comput. Assist. Tomography, 11: 398-402.
100. Gemmell, H.G., Sharp, P.F. and Smith, F.W., et al. (1989) Cerebral blood flow measured by SPECT as a diagnostic tool in the study of dementia. Psychiatry Res., 29: 327-329.
101. Gentry, L.R., Godersky, J.C. and Thompson, B. (1988b) MR imaging of head trauma, review of the distribution and radiopahtologic features of traumatic lesions. A.J.R., 150: 663-672.
102. Gentry, L.R., Godersky, J.C. and Thompson, B., et al. (1988a) Prospective comparative study of intermediate-field MR and CT in the evaluation of closed head trauma. A.J.R., 150: 673-682.
103. George, A.E., deLeon, M.J. and Gentes, C.I., et al. (1986a) Leukoencephalopathy in normal aging and pathologic aging: 1. CT of brain lucencies. A.J.N.R., 7: 561-566.
104. George, A.E., deLeon, M.J. and Kalnin, A., et al. (1986b) Leukoencephalopathy in normal aging and pathologic aging: 2. MRI of brain lucencies. A.J.N.R., 7: 567-570.
105. George, A.E., Stylopolous, L.A. and deLeon, M.J., et al. (1987) Temporal lobe CT diagnostic features of Alzheimer's disease. A.J.N.R., 8: 931 (Abstract).
106. George, J.K., Alavi, A. and Zimmerman, R.A., et al. (1989) Metabolic (PET) correlates of anatomic lesions (CT/MRI) produced by head trauma. J. Nucl. Med., 30: 802. (Abstr.).
107. Gibbs, J., Frackowiak, R. and Legg, N. (1986) Regional cerebral blood flow and oxygen metabolism in dementia due to vascular disease. Gerontol., 32: 84-89. (suppl 1).
108. Gibbs, J., Wise, R. and Leenders, K., et al. (1984) Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet, i: 310-314.
109. Grady, C.L., Haxby, J.V. and Schlageter, N.L., et al. (1986) Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type. Neurology, 36: 1390-1392.
110. Gray, B.G., Ichise, M. and Chung, D-G., et al. (1992) Technetium-99m-HMPAO SPECT in the evaluation of patients with a remote history of traumatic brain injury, a comparision with x-ray computed tomography. J. Nucl. Med., 33: 52-58.
111. Gur, R.C., Mozley, P.D. and Resnick, S.M., et al. (1991) Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. Proc. Natl. Acad. Sci. USA, 88: 2845-2849.
112. Hagglund, J., Aquilonius, S.M. and Eckernas, S.A., et al. (1987) Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-methyl-spiperone. Acta Neurol. Scand., 75: 87-94.
113. Haug, G. (1977) Age and sex dependence of the size of normal ventricles on computed tomography. Neuroradiology, 14: 201-204.
114. Haxby, J.C., Duara, R. and Grady, C.L., et al. (1985) Relationship between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J. Cerebr. Blood Flow Metab., 5: 193-200.
115. Haxby, J.C., Grady, C.L. and Duara, R., et al. (1986) Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Arch. Neurol., 43: 882-885.
116. Hayden, M.R., Hewitt, J. and Martin, W.R.W., et al. (1987) Studies in persons at risk for Huntington's disease. N.E.J.M., 317: 382-383.
117. Hayden, M.R., Martin, W.R.W. and Stoessl, A.J., et al. (1986) Positron emission tomography in the early diagnosis of Huntington's disease. Neurology, 36: 888-894.
118. Hayman, L.A., Taber, K.H. and Jhingran, S.G., et al. (1989) Cerebral infarction. Diagnosis and assessment of prognosis by using 123 IMP SPECT and CT. A.J.N.R., 10: 557-562.
119. Heiss, W., Pawlik, G. and Hebold, I., et al. (1989) Can positron emission tomography be used to gauge the brain's capacity for functional recovery following stroke? In: Ginsberg, M. and Dietrich, W. (Eds.) Cerebrovascular Diseases (16th Research Princeton Conference), Raven, New York, pp. 345-352.
120. Heiss, W., Zeiler, K. and Havelec, L., et al. (1988) Long-term prognosis in stroke related to cerebral blood flow. Arch. Neurol., 34: 671-676.
121. Heiss, W.D., Kessler, J. and Szelies, B., et al. (1991) Positron emission tomography in the differential diagnosis of organic dementias. J. Neural Transm. (Suppl.) 33: 13-19.
122. Herholz, K., Ziffling, P. and Staffen, W., et al. (1988) Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET. Europ. J. Cancer Clin. Oncol., 24: 1139-1150.
123. Holman, B.L., Johnson, K.A. and Garada, B., et al. (1992) The scintigraphic appearance of Alzheimer's disease, a prospective study using technetium-99m-HMPAO SPECT. J. Nucl. Med., 33: 181-185.
124. Huber, S.J., Shuttleworth, E.C. and Christy, J.A., et al. (1989) Magnetic resonance imaging in dementia of Parkinson's disease. J. Neurol. Neurosurg Psychiatry, 52: 1221-1227.
125. Hurwitz, T.A., Ammann, W. and Chu, D., et al. (1991) Single photon emission computed tomography using 99mTc-HM-PAO in the routine evaluation of Alzheimer's disease. Can. J. Neurol. Sci., 18: 59-62.
126. Jackson, G.D., Connelly, A. and Cross, J.H., et al. (1994) Functional magnetic resonance imaging of focal seizures. Neurology, 44: 850-856.
127. Jaeckle, K.A. (1991) Neuroimaging for central nervous system tumors. Semin. Oncol., 10: 150-7.
128. Jagust, W.J., Budinger, T.F. and Reed, B.R., et al. (1987) The diagnosis of dementia with single photon emission computed tomography. Arch. Neurol., 44: 258-262.
129. Jagust, W.J., Friedland, R.P. and Budinger, T.F., et al. (1988) Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology, 38: 909-912.
130. Jamieson, D.G., Chawluck, J.B. and Alavi, A., et al. (1987) The effect of disease severity on local cerebral glucose metabolism in Alzheimer's disease. J. Cerebr. Blood Flow Metab. 7: S410.
131. Jenkins, I.H., Fernandez, W. and Playford, et al. (1992) Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann. Neurol., 32: 749-757.
132. Jennett, B. (1991) Diagnosis and management of head trauma. J. Neurotrauma 8: S15-19. (Suppl.).
133. Jernigan, T.L., Salmon, D.P. and Butters, N., et al. (1991) Cerebral structure on MRI. Part II, Specific changes in Alzheimer's and Huntington's diseases, Biol. Psychiatry, 29: 68-81.
134. Johnson, K.A., Holman, B.L. and Rosen, T.J., et al. (1990) Iofetamine I-123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease. Arch. Intern. Med., 150: 752-756.
135. Jolles, P.R., Chapman, P.R. and Alavi, A. (1989) PET, CT and MRI in the evaluation of neuropsychiatrie disorders, current applications. J. Nucl. Med., 30: 1589-1606.
136. Kelly, A.B., Zimmerman, R.D. and Snow, R.B., et al. (1988) Head trauma, comparison of MR and CT-experience in 100 patients. A.J.N.R., 9: 699-708.
137. Kelly, W.M. and Brant-Zawadski, M. (1988) Magnetic Resonance imaging and computed tomography of supratentorial tumors. In: Taveras, J.M. and Ferrucci, J.T. (Eds.) Radiology, Diagnosis-Imaging-Intervention. J.P. Lippincott, Philadelphia.
138. Kertesz, A., Polk, M. and Carr, T. (1990) Cognitive and white matter changes on magnetic resonance imaging in dementia. Arch. Neurol., 47: 1135-1140.
139. Kim, K.T., Black, K.L. and Marciano, D., et al. (1990) Thallium SPECT imaging of brain tumors, methods and results. J. Nucl. Med., 31: 965-969.
140. Knapp, W.H., von Kummer, R. and Kubler, W. (1986) Imaging of cerebral blood flow-to-volume distribution using SPECT. J. Nucl. Med., 27: 465-470.
141. 3. Ann. Neurol., 8: 47-69.
142. Kuhl, D.E., Metter, E.J. and Benson, D.F., et al. (1985) Similarities of cerebral glucose metabolism in Alzheimier's and parkinsonian demetia. J. Nucl. Med., 26: P69. (Abstr.).
143. Kuhl, D.E., Metter, E.J. and Riege, W.H., et al. (1984) Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Ann. Neurol., 15 (Suppl): S119-S125.
144. Kuhl, D.E., Metter, E.J. and Riege, W.H., et al. (1987) Effects of human aging on patterns of local cerebral glucose utilization determined by the 18-F fluorodeoxyglucose method, J. Cerebr. Blood Flow Metab., 7: S411.
145. Kuhl, D.E., Phelps, M.E. and Markham, C.H., et al. (1982) Cerebral metabolism and atrophy in Huntington's disease determined by 18-FFDG and computed tomographic scan. Ann. Neurol., 12: 425-434.
146. Kumar, A., Schapiro, M.B. and Grady, C., et al. (1991) High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacol., 4: 35-46.
147. Kushner, M., Alavi, A. and Reivich, M., et al. (1984) Contralateral cerebellar hypometabolism following cerebral insult, a positron emission tomographic study. Ann. Neurol., 15: 425-434.
148. Kushner, M., Reivich, M. and Fieschi, C., et al. (1987a) Metabolic and clinical correlates of acute ischemic infarction. Neurol., 37: 1103-1110.
149. Kushner, M., Tobin, M. and Alavi, A., et al. (1987b) Cerebellar glucose consumption in normal and pathologic slates using fluorine-FDG and PET. J. Nucl. Med., 28: 1667-1670.
150. Kuwabara, Y., Ichiya, Y. and Otsuka, M., et al. (1990a) Comparison of I-123 and Tc-99m HMPAO SPECT studies with PET in dementia. Ann. Nucl. Med., 4: 75-82.
151. Kuwabara, Y., Ichiya, Y. and Otsuka, M., et al. (1990b) Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging. Clin. Nucl. Med., 15: 893-899.
152. Kuwert, T., Lange, H.W. and Langen, K.J., et al. (1990) Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain, 113: 1405-1423.
153. Lammertsma, A., Wise, R. and Gibbs, J., et al. (1983) The pathophysiology of human cerebral tumors and surrounding white matter and remote cortex. J. Cerebr. Blood Flow Metab., 3 (Suppl 1): S9-S10.
154. Lang, D.A., Hadley, D.M. and Teasdale, G.M., et al. (1991) Gadolinium enhanced magnetic resonance imaging in acute head injury. Acta Neurochir., 109: 5-11.
155. Langfitt, T.W., Obrist, W.D. and Alavi, A., et al. (1986) Computerized tomography, magnetic resonance imaging and positron emission tomography in the study of brain trauma. Preliminary observations. J. Neurosurg., 64: 760-767.
156. Lassen, N. (1966) The luxury perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain. Lancet, ii: 1113-1115.
157. Lassen, N. (1990) Pathophysiology of brain ischemia as it relates to the therapy of acute ischemic stroke. Clin. Neuropharmacol., 13 (Suppl.), S1-8.
158. Latack, J.T., Abou-Khalil, B.W. and Siegel, G.J., et al. (1986) Patients with partial seizure, evaluation by MR, CT and PET imaging. Radiology, 159: 159-163.
159. Launes, J., Sulkava, R. and Erkinjuntti, T., et al. (1991) 99Tcm-HMPAO SPECT in suspected dementia. Nucl. Med. Comm., 12: 757-765.
160. Leblanc, R. (1991) Physiologic studies of cerebral ischemia. Clin. Neurosurg., 37: 289-311.
161. Leblhuber, F., Holl, K. and Gebetsberger, B., et al. (1987) Long latency responses (LLRs) and IMP-SPECT findings in early detection of Huntington's chorea. Electroencephalogr. Clin. Neurophysiol., 66: S59.
162. Lechner, H., Schmidt, R. and Goetz, B. (1990) Long term experience of a trial in multi-infarct dementia. Neuroepidemiology, 9: 228-232.
163. Lee, R.G.L., Hill, T.C. and Holman, B.L., et al. (1984) Predictive value of perfusion defect size using N-isopropyl-(I123)-p-iodoamphetamine emission tomography in acute stroke. J. Neurosurg., 61: 449-452.
164. Leenders, K.L., Palmer, A.J. and Quinn, N., et al. (1986) Brain dopamine metabolism in patientrs with Parkinson's disease measured with positron emission tomography. J. Neurol. Neurosurg. Psych., 49: 853-860.
165. Leenders, K.L., Salmon, E.P. and Tyrrell, P., et al. (1990) The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch. Neurol., 47: 1290-1298.
166. Levin, H.S., Williams, D.H. and Eisenberg, H.M., et al. (1992) Serial MRI and neurobehavioral findings after mild to moderate closed head injury. J. Neurol. Neurosurg. Psych., 55: 255-67.
167. Malko, J.A., Hoffman, J.C. and Green, R.C. (1991) MR measurement of intracranial CSF volume in 41 elderly normal volunteers. A.J.N.R., 12: 371-374.
168. Marchal, G., Evans, A. and Dagher, A., et al. (1987) The evolution of cerebral infarction with time, A PET study of the ischemia penumbra. J. Cerebr. Blood Flow Metab., 7: S99. (Suppl I).
169. Martin, W.R.W., Stoessel, A., et al. (1986) Positron emission tomography in Parkinson's disease, Glucose and dopa metabolism. Adv. Neurol., 45: 95-98.
170. Matsuzawa, T., Matsui, H. and Meguro, K., et al. (1990) Characteristics of cerebral glucose utilization in dementia. Sci. Rep. Res. Tohoku Univ., 37: 11-12.
171. Maurer, A.H., Vitti, R.A. and Brooks, A., et al. (1988) Significance of patterns of I-123 iodoamphetamine redistribution for predicting successful revascularization following carotid endarterectomy. J. Nucl. Med., 29: 844. (abstr.).
172. Mazziotta, J.C. (1989) Huntington's disease, studies with structural imaging techniques and positron emission tomography. Semin. Neurol., 9: 360-369.
173. Mazziotta, J.C., Frackowiak, R.S.J. and Phelps, M.E. (1992) The use of positron emission tomography in the clinical assessment of dementia. Semin. Nucl. Med., 22: 232-246.
174. Mazziotta, J.C., Phelps, M.E., Pahl, J.J., et al. (1987) Reduced cerebral glucose metabolism in asymptomatic patients at risk for Huntington's disease. N.E.J.M., 316: 357-362.
175. McClure, R.J., Kanfer, J.N. and Panchalingam, K., et al. (1995) Magnetic resonance spectroscopy and its application to aging and Alzheimer's disease. Neuroimaging Clin. N. Am., 5: 69-86.
176. McGeer, P.L., Kamo, H. and Harrop, R., et al. (1986) Comparison of PET, MRI and CT with pathology in a proven case of Alzheimer's disease. Neurology, 36: 1569-1574.
177. Meneghetti, G., Vorstupt, S. and Mickey, B. (1984) Crossed cerebellar diaschisis in ischemic stroke, A study of regional cerebral blood flow by 133 Xe inhalation and single-photon emission computerized tomography. J. Cerebr. Blood Flow Metab., 4: 235-240.
178. Meyer, E., Delpia, P. and Petrides, M., et al. (1991) PET metabolic and neuropsychological correlates of periventricular lucencies. In: Hartmann, A., Kuschinsky, W. and Hoyer, S. (Eds.) Cerebral Ischemia and Dementia, Springer-Verlag, Berlin.
179. Moretti, J.L., Defer, G. and Cesaro, P., et al. (1987) Early and delayed IMP I-123 SPECT as a prognostic index for clinical recovery in cerebral ischemia. J. Nucl. Med., 28: 623 (Abstr.).
180. Moretti, J.L., Defer, G. and Cinotti, L., et al. (1990) 'Luxury-perfusion' with Tc-99m-d, 1 HM-PAO and I-123-IMP SPECT imaging during the subacute phase of stroke. Eur. J. Nucl. Med., 16: 17-22.
181. Morris, G.L. 3rd., Mueller, W.M. and Yetkin, F.Z., et al. (1994) Functional magnetic resonance imaging in partial epilepsy. Epilepsia, 35: 1194-1198.
182. Nagel, J.S., Ichise, M. and Holman, B.L. (1991) The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans. Semin. Nucl, Med., 21: 11-23.
183. Nagel J.S., Johnson, K.A. and Ichise, M., et al. (1988) Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease. Clin. Nucl. Med., 13: 486-490.
184. New, P.F.J., Aronow, S. and Hesselink, J.R. (1980) National Cancer Institute Study, Evaluation of computed tomography in the diagnosis of intracranial neoplasms. IV, Meningiomas. Radiology, 136: 665-675.
185. Newton, M.R., Greenwood, R.J. and Britton, K.E., et al. (1992) A study comparing SPECT with CT and MRI after closed head injury. J. Neurol. Neurosurg. Psychiatry, 55: 92-94.
186. Och, R.F., Yamamoto, Y. and Gloor, P. (1984) Correlations between the positron emission tomography measurement of glucose metabolism and oxygen utilization in focal epilepsy. Neurol., 34 (Suppl. 1): 125.
187. Ogawa, T., Uemura, K. and Shishido, F., et al. (1988) Changes of cerebral blood flow and oxygen and glucose metabolism following radiochemotherapy of gliomas, A PET study. J. Comput. Assist. Tomography, 12: 290-297.
188. Ogawa, T., Sekino, H. and Uzura, M., et al. (1992) Comparative study of magnetic resonance and CT scan imaging in cases of severe head injury. Acta Neurochir (Suppl.), 55: 8-10.
189. Ohnishi, T., Hoshi, H. and Nagamachi, S., et al. (1991) Regional cerebral blood flow study with 123I-IMP in patients with degenerative dementia. A.J.N.R., 12: S13-S20.
190. Olanow, C.W. (1992) Magnetic resonance imaging in parkinsonism. Neurol. Clin., 10: 405-420.
191. Pahl, J.J. (1989) Cerebral metabolic decline, A biochemical marker of genetic expression in Huntington's disease. Adv. Functional Neuroimag., 2: 3-8.
192. Pantano, P., Baron, J.C. and Samson, Y., et al. (1986) Crossed cerebellar diaschisis. Further studies. Brain, 109: 677-694.
193. Pardo, F.S., Aronen, H.J. and Kennedy, D., et al. (1994) Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. International J. Rad. Onc., Biol., Physics, 30: 663-669.
194. Patronas, N.J., Brooks, R.A. and DeLaPaz, R.L., et al. (1983) Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. A.J.N.R., 4: 533-535.
195. Patronas, N.J., DiChiro, G. and Smith, B.H., et al. (1984) Depressed cerebellar glucose metabolism in supratentorial tumors. Brain Res., 291: 93-101.
196. Pawlik, G., Holthoff, V. and Rudolf, J., et al. (1989) Vasculitic dementia. Characteristic changes of regional brain function demonstrated by PET. J. Cerebr. Blood Flow Metab., 9: S534. (suppl I).
197. Peppard, R.F., Martin, W.R. and Clark, C.M., et al. (1990) Cortical glucose metabolism in Parkinson's and Alzheimer's disease. J. Neurosci. Res., 27: 561-568.
198. Perani, D., DiPiero, V. and Lucignani, G., et al. (1988a) Remote effects of subcortical cerebrovascular lesions, A SPECT cerebral perfusion study. J. Cerebr. Blood Flow Metab., 8: 5640-5647.
199. Perani, D., DiPiero, V. and Vallar, G., et al. (1988b) Technetium-99m HM-PAO SPECT study of regional cerebral perfusion in early Alzheimer's disease. J. Nucl. Med., 29: 1507-1514.
200. Perani, D., Gerundini, P. and Lenzi, G.L. (1987) Cerebral hemispheric and contralateral cerebellar hypoperfusion during a transient ischemic attack. J. Cerebr. Blood Flow Metab., 7: 507-509.
201. Pettegrew, J.W., Panchalingam, K., Klunk, W.E., et al. (1994) Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study. Neurobiol. Aging, 15: 117.
202. Pfefferbaum, A., Sullivan, E.V. and Jernigan, T.L., et al. (1990) A quantitative analysis of CT and cognitive measures in normal aging and Alzheimer's disease. Psych. Res. Neuroimaging, 35: 115-136.
203. Phelps, M.E. and Mazziotta, J.C. (1985) Positron emission tomography, Human brain function and biochemistry. Science, 228: 799-809.
204. Pizzolato, G., Dam, M. and Borsato, N., et al. (1988) Tc-99m-HM-PAO SPECT in Parkinson's disease. J. Cerebr. Blood Flow Metab., 8: S101-S108.@A1
205. Playford, E.D., Jenkins, I.H, and Passingham, R.E., et al. (1992) Impaired mesial frontal and putamen activation in Parkinson's disease, a positron emission tomography study. Ann. Neurol., 32: 151-161.
206. Playford, E.D., Jenkins, I.H. and Passingham, R.E., et al. (1993) Impaired activation of frontal areas during movement in Parkinson's disease, a PET study. Adv. Neurol., 60: 506-510.
207. Podreka, I., Suess, E. and Goldberg, G., et al. (1987) Initial experience with technetium-99m HM-PAO brain SPECT. J. Nucl. Med., 28: 1657-1666.
208. Powers, W., Grubb, R. and Raichle, M. (1984a) Physiological response to focal cerebral ischemia in humans. Ann. Neurol., 16: 546-552.
209. Powers, W., Martin, W. and Herscovitch, P., et al. (1984b) Extracranial-intracranial bypass surgery; hemodynamic and metabolism effects. Neurology, 34: 1168-1174.
210. Powers, W., Grubb, R. and Raichle, M. (1989) Clinical results of extracranial-intracranial bypass-surgery in patients with hemodynamic cerebrovascular disease, J. Neurosurg., 70: 61-67.
211. Putty, T.K., Luerssen, T.G. and Campbell, R.L., et al. (1990-91) Magnetic resonance imaging diagnosis of cerebral aneurysm in an infant. Case report and review of the literature. Ped. Neurosurg., 16: 48-51.
212. Rango, M., Candelise, L. and Perani, D., et al. (1989) Cortical pathophysiology and clinical neurological abnormalities in acute cerebral ischemia, A serial study with single photon emission computed tomography. Arch. Neurol., 46: 1318-1322.
213. Reid, I.C., Besson, J.A. and Best, P.V., et al. (1988) Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography. J. Neurol. Neurosurg. Psych., 51: 1264-1268.
214. Reid, R.H., Gulenchyn, K.Y. and Ballinger, J.R., et al. (1990) Cerebral perfusion imaging with technetium-99m HMPAO following cerebral trauma, initial experience. Clin. Nucl. Med., 15: 383-388.
215. Robitaille, Y., Rasmussen, T. and Dubeau, F., et al. (1992) Histopathology of nonneoplastic lesions in frontal lobe epilepsy, review of 180 cases with recent MRI and PET correlations. Adv. Neurol., 57: 499-511.
216. Rougemont, D., Baron, J.C., Collard, P., et al. (1984) Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease. J. Neurol. Neurosurg, Psych., 47: 824-830.
217. Rozental, J.M., Levine, R.L. and Nickles, R.J., et al. (1991) Changes in glucose uptake by malignant gliomas, preliminary study of prognostic significance. J. Neurooncol., 10: 75-83.
218. Ruff, R.M., Buchsbaum, M.S. and Troster, A.I., et al. (1989) Computerized tomography, neuropsychology and positron emission tomography in the evaluation of head injury. Neuropsych. Neuropsychol. Behav. Neurol., 2: 103-123.
219. Samson, Y., Baron, J. and Bousser, M. (1985) Effects of extra-intracranial arterial bypass on cerebral blood flow and oxygen metabolism in humans. Stroke, 16: 609-616.
220. Savic, I., Persson, A. and Roland, P., et al. (1988) In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet ii: 863-866.
221. Sawada, H., Udaka, F., Kameyama, M., et al. (1992) SPECT findings in Parkinson's disease associated with dementia. J. Neurol. Neurosurg. Psychiatry, 55: 960-963.
222. Sawle, G.V. (1992) The detection of preclinical Parkinson's disease, what is the role of positron emission tomography? Movement Dis., 8: 271-277.
223. Sawle, G.V., Wroe, S.J. and Lees, A.J., et al. (1992b) The identification of presymptomatic parkinsonism, clinical and [18F]dopa positron emission tomography studies in an Irish kindred. Ann. Neurol., 32: 609-617.
224. Schlageter, N.L., Horwitz, B. and Creasey, H., et al. (1987) Relation of measured brain glucose utilization and cerebral atrophy in man. J. Neurol. Neurosurg. Psychiatry 50: 779-785.
225. Schwartz, R.B., Carvalho, P.A. and Alexander, E. III, et al. (1991) Radiation necrosis vs high-grade recurrent glioma, differentiation by using dual-isotope SPECT with 201TI and 99mTc-HMPAO. A.J.N.R., 12: 1187-1192.
226. Sette, G., Baron. J. and Mazoyer, B., et al. (1989) Local brain hemodynamics and oxygen metabolism in cerebrovascular disease. Brain, 112: 931-951.
227. Simmons, J.T., Pastakea, B. and Chase, T.N., et al. (1986) Magnetic resonance imaging in Huntington's disease. A.J.N.R., 7: 25-28.
228. Sklar, E.M., Quencer, R.M. and Bowen, B.C., et al. (1992) Magnetic resonance applications in cerebral injury. Radiol. Clin. North Am., 30: 353-366.
229. Smith, F.W., Besson, J.A. and Gemmell, H.G., et al. (1988) The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatrie conditions. J. Cerebr. Blood Flow Metab., 8: 6: S116-122.
230. Smith, F.W., Besson, J.A. and Gemmell, H.G., et al. (1988b) Technetium-99m HMPAO imaging in patients with basal ganglia disease. Br. J. Radiol., 61: 914-920.
231. Sperling, M.R., Wilson, G. and Engel, J. Jr., et al. (1986) Magnetic resonance imaging in intractable partial epilepsy, correlative studies. Ann. Neurol., 20: 57-62.
232. Spetzler, R.F., Zabramski, J.M. and Kaufman, B., et al. (1983) Acute NMR changes during MCA occlusion, a preliminary study of primates. Stroke, 14: 185-190.
233. Starkstein, S.E., Folstein, S.E. and Brandt, et al. (1989) Brain atrophy in Huntington's disease, A CT-scan study. Neuroradiol., 31: 156-159.
234. Stefan, H., Pawlik, G. and Bocher-Schwarz, H.G., et al. (1987) Functional and morphologic abnormalities in temporal lobe epilepsy, A comparison of interictal and ictal EEG, CT, MRI, SPECT and PET. J. Neurol., 234: 377-384.
235. Sullivan, H.G., Kingsbury, T.B. IV and Morgan, M.E., et al. (1987) The rCBF response to Diamox in normal subjects and cerebrovascular disease patients. J. Neurosurg., 67: 525-534.
236. Swartz, B.E., Tomiyasu, U., Delgado-Escueta, A.V., et al. (1992) Neuroimaging in temporal lobe epilepsy, test sensitivity and relationships to pathology and postoperative outcome. Epilepsia, 33: 624-634.
237. Tanna, N.K., Kohn, M.I. and Horwich, D.N., et al. (1991) Analysis of brain and cerebrospinal fluid volumes with MR imaging: Impact on PET data, correction for atrophy. Radiology, 178: 123-130.
238. Testa, H.J., Snowden, J.S. and Neary, D., et al. (1988) The use of Tc-99m HM-PAO in the diagnosis of primary degenerative dementia. J. Cerebr. Blood Flow Metab., 8: S123-S126.
239. Theodore, W.H., Brooks, R. and Sato, S., et al. (1984) The role of positron emission tomography in the evaluation of seizure disorders. Ann. Neurol., 15: S1176-S1179. (Suppl).
240. Theodore, W.H., Dorwart, R. and Holmes, M., et al. (1986) Neuroimaging in refractory partial seizures. Comp. PET, CT, MRI. Neurol., 36: 750-759.
241. Theodore, W.H., Newmark, M.E. and Sato, S., et al. (1983) 18F fluorodeoxyglucose positron emission tomography in refractory complex partial seizures. Ann. Neurol., 14: 537.
242. Toghi, H., Chiba, K. and Sasaki, K., et al. (1991) Cerebral perfusion patterns in vascular dementia of Binswanger type compared with senile dementia of the Alzheimer type, a SPECT study. J. Neurol., 238: 365-370.
243. Valk, P.E., Budinger, T.F. and Levin, V.A., et al. (1988) Positron emission tomography of malignant cerebral tumors after interstitial brachytherapy, Demonstration of metabolic activity and correlation with clinical outcome. J. Neurosurg., 69: 830-838.
244. Vallar, G., Perani, D. and Cappa, S.F., et al. (1988) Recovery from aphasia and neglect after subcortical stroke, neuropsychological and cerebral perfusion study. J. Neurol. Neurosurg. Psych., 51: 1269-1276.
245. Wahlund, L.O., Agartz, I. and Almqvist, O., et al. (1990) The brain in healthy aged individuals: MR imaging. Radiol., 174: 675-679.
246. Wallner, K.E., Galicich, J.H. and Malkin, M.G., et al. (1989) Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation. J. Clin. Oncol., 7: 1492-1496.
247. Wang, A-M., Lin, J.C-T. and Rumbaugh, C.L. (1988) What is expected of CT in the evaluation of stroke? Neuroradiol., 30: 54-58.
248. Weinstein, H.C., Hean, J. and van Royen, E.O., et al. (1991) SPECT in the diagnois of Alzheimer's disease and multi-infarct-dementia. Clin. Neurol. Neurosurg., 93: 39-43.
249. Weisberg, L.A. (1990) How to identify and manage brain hemorrhage. Postgrad. Med., 88: 169-175.
250. Weiss, D., Souder, E. and Alavi, A., et al. (1990) Effects of normal aging on whole brain and regional glucose metabolism as assessed by F-18 positron emission tomography. J. Nucl. Med., 31: 771.
251. Wilson, C.B. (1989) Metabolic imaging of human brain tumors. Semin. Neurol., 9: 388-393.
252. Wise, R., Bernardi, S. and Frackowiak, R., et al. (1983) Serial observations on the pathophysiology of acute stroke, The transition from ischemia to infarction as reflected in regional oxygen extraction. Brain, 106: 197-222.
253. Wong, D.F., Links, J.M. and Wagner, H.N., et al. (1985) Dopamine and serotonin receptors measured in vivo in Huntington's disease with c-11 -N-methylspiperone PET imaging. J. Nucl. Med., 26: P107. (Abstr.).
254. Wszolek, Z.K., Herkes, G.K. and Lagerlund, T.D., et al. (1992) Comparison of EEG background frequency analysis, psychologic test scores, short test of mental status and quantitative SPECT in dementia. J. Geriatric Psych. Neurol., 5: 22-30.
255. Yao, H., Sadoshima, S. and Kuwabara, Y., et al. (1990) Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke, 21: 1694-1699.
256. Yealy, D.M. and Hogan, D.E. (1991) Imaging after head trauma, Who needs what? Emerg. Med. Clin. North Am., 9: 707-717.
257. Yoshii, F., Barker, W.W. and Chang, J.Y., et al. (1988) Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy and cerebrovascular risk factors. J. Cerebr. Blood Flow Metab., 8: 654-661.
258. Young, A.B., Penney, J.B. and Starosta-Rubinstein, S., et al. (1987) Normal caudate glucose metabolism in persons at risk for Huntington's disease. Arch. Neurol., 44: 254-257.
259. Young, A.V., Penney, J.B. and Starosta-Rubinstein, S., et al. (1986) PET scan investigations of Huntington's disease, Cerebral metabolic correlates of neurological features and functional decline. Ann. Neurol., 29: 296-303.
260. Zatz, L.M., Jernigan, T.L. and Ahumada, A.J. Jr. (1982) Changes on computed cranial tomography with aging: intracranial fluid volume. A.J.N.R., 3: 1-11.
261. Zee, C.S., Chin, T. and Segall, H.D., et al. (1992) Magnetic resonance imaging of meningiomas. Semin. Ultrasound, CT MR, 13: 154-169.
262. Zimmerman, R.A., Bilaniuk, L.T. and Hackney, D.B., et al. (1986a) Head injury, early results comparing CT and high-field MR. A.J.R., 147: 1215-1222.
263. Zimmerman, R.D., Flemming, C.A. and Lee, B.C.P., et al. (1986b) Periventricular hyperintensity as seen by magnetic resonance, prevalence and significance. A.J.N.R., 7: 13-20.